| Target Price | ¥2,040.00 |
| Price | ¥2,036.50 |
| Potential |
0.17%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Olympus 2026 .
The average Olympus target price is ¥2,040.00.
This is
0.17%
register free of charge
¥3,582.60
75.92%
register free of charge
¥1,767.50
13.21%
register free of charge
|
|
| A rating was issued by 19 analysts: 8 Analysts recommend Olympus to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Olympus stock has an average upside potential 2026 of
0.17%
register free of charge
|
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 997.33 | 988.24 |
| 6.53% | 0.91% | |
| EBITDA Margin | 22.29% | 20.00% |
| 36.47% | 10.29% | |
| Net Margin | 11.82% | 8.94% |
| 54.39% | 24.35% |
14 Analysts have issued a sales forecast Olympus 2026 . The average Olympus sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Olympus EBITDA forecast 2026. The average Olympus EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Olympus Analysts have issued a net profit forecast 2026. The average Olympus net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 102.98 | 78.32 |
| 48.36% | 23.95% | |
| P/E | 26.37 | |
| EV/Sales | 2.37 |
14 Analysts have issued a Olympus forecast for earnings per share. The average Olympus EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


